Literature DB >> 15659734

Topical microbicides become topical.

John P Moore1.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15659734     DOI： 10.1056/NEJMcibr043727

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide.

Authors:  Hubert Gaertner; Fabrice Cerini; Jean-Michel Escola; Gabriel Kuenzi; Astrid Melotti; Robin Offord; Irène Rossitto-Borlat; Rebecca Nedellec; Janelle Salkowitz; Guy Gorochov; Donald Mosier; Oliver Hartley
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-12       Impact factor: 11.205

2.  Syndecan-Fc hybrid molecule as a potent in vitro microbicidal anti-HIV-1 agent.

Authors:  Michael D Bobardt; Udayan Chatterji; Lana Schaffer; Lot de Witte; Philippe A Gallay
Journal:  Antimicrob Agents Chemother       Date:  2010-05-03       Impact factor: 5.191

3.  Sublimable C5A delivery provides sustained and prolonged anti-HIV microbicidal activities.

Authors:  Richard Maskiewicz; Michael Bobardt; Udayan Chatterji; Simi Gunaseelan; Charlene S Dezzutti; Francois Penin; Philippe A Gallay
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

Review 4.  Update: preventing mother-to-child transmission of HIV.

Authors:  Mary A Vogler
Journal:  Curr HIV/AIDS Rep       Date:  2006-07       Impact factor: 5.071

5.  Inactivation of herpes simplex virus clinical isolates by using a combination microbicide.

Authors:  Charles E Isaacs; Lisa Rohan; Weimin Xu; Jun Hua Jia; Timothy Mietzner; Sharon Hillier
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

6.  Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challenge.

Authors:  Ronald S Veazey; Binhua Ling; Linda C Green; Erin P Ribka; Jeffrey D Lifson; Michael Piatak; Michael M Lederman; Donald Mosier; Robin Offord; Oliver Hartley
Journal:  J Infect Dis       Date:  2009-05-15       Impact factor: 5.226

7.  C5A Protects Macaques from Vaginal Simian-Human Immunodeficiency Virus Challenge.

Authors:  Ronald S Veazey; Udayan Chatterji; Michael Bobardt; Kasi E Russell-Lodrigue; Jian Li; Xiaolei Wang; Philippe A Gallay
Journal:  Antimicrob Agents Chemother       Date:  2015-11-09       Impact factor: 5.191

8.  Maraviroc in the treatment of HIV infection.

Authors:  Neelanjana Ray
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

9.  A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastoris.

Authors:  Fabrice Cerini; Hubert Gaertner; Knut Madden; Ilya Tolstorukov; Scott Brown; Bram Laukens; Nico Callewaert; Jay C Harner; Anna M Oommen; John T Harms; Anthony R Sump; Robert C Sealock; Dustin J Peterson; Scott K Johnson; Stephan B Abramson; Michael Meagher; Robin Offord; Oliver Hartley
Journal:  Protein Expr Purif       Date:  2015-10-24       Impact factor: 1.650
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.